pillbase.ru

Vanflyta

Active substance: quizartinib

quizartinib dihydrochloride

Centralised EU authorisationActive

Marketing holder: Daiichi Sankyo Europe GmbH

Verified 2026-10-09 · EMA

Analogues in other countries
Composition
Analogues by country

Products with the same active substance registered in other countries.

CountryProducts
US 2
  • VANFLYTA
    TABLET, FILM COATED · QUIZARTINIB DIHYDROCHLORIDE 17.7 mg/1
    65597-504
    Daiichi Sankyo Inc.
  • VANFLYTA
    TABLET, FILM COATED · QUIZARTINIB DIHYDROCHLORIDE 26.5 mg/1
    65597-511
    Daiichi Sankyo Inc.
Import and control

Control by country

  • United Statesprescription only

    Source: openFDA NDC · record 01a1208c-98f4-7490-bb9c-eef6239ff0f0,01a12096-e8aa-75ff-b76f-6ad4378713c0;count=2 · valid from 2026-10-09 · verified 2026-10-09

More on control status
Registration
Registration number
EMEA/H/C/004468
Registration status
Active
ATC code
L01XE
Sources
  • product · EMA · EMEA/H/C/004468 · Verified 2026-10-09
  • registration_status · EMA · EMEA/H/C/004468 · Verified 2026-10-09
  • ingredients.0 · EMA · EMEA/H/C/004468 · Verified 2026-10-09